Literature DB >> 33462412

The regulation of necroptosis by post-translational modifications.

Yanxiang Meng1,2, Jarrod J Sandow1,2, Peter E Czabotar1,2, James M Murphy3,4.   

Abstract

Necroptosis is a caspase-independent, lytic form of programmed cell death whose errant activation has been widely implicated in many pathologies. The pathway relies on the assembly of the apical protein kinases, RIPK1 and RIPK3, into a high molecular weight cytoplasmic complex, termed the necrosome, downstream of death receptor or pathogen detector ligation. The necrosome serves as a platform for RIPK3-mediated phosphorylation of the terminal effector, the MLKL pseudokinase, which induces its oligomerization, translocation to, and perturbation of, the plasma membrane to cause cell death. Over the past 10 years, knowledge of the post-translational modifications that govern RIPK1, RIPK3 and MLKL conformation, activity, interactions, stability and localization has rapidly expanded. Here, we review current knowledge of the functions of phosphorylation, ubiquitylation, GlcNAcylation, proteolytic cleavage, and disulfide bonding in regulating necroptotic signaling. Post-translational modifications serve a broad array of functions in modulating RIPK1 engagement in, or exclusion from, cell death signaling, whereas the bulk of identified RIPK3 and MLKL modifications promote their necroptotic functions. An enhanced understanding of the modifying enzymes that tune RIPK1, RIPK3, and MLKL necroptotic functions will prove valuable in efforts to therapeutically modulate necroptosis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33462412      PMCID: PMC7937688          DOI: 10.1038/s41418-020-00722-7

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  183 in total

1.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury.

Authors:  Alexei Degterev; Zhihong Huang; Michael Boyce; Yaqiao Li; Prakash Jagtap; Noboru Mizushima; Gregory D Cuny; Timothy J Mitchison; Michael A Moskowitz; Junying Yuan
Journal:  Nat Chem Biol       Date:  2005-05-29       Impact factor: 15.040

Review 2.  Necroptosis: the release of damage-associated molecular patterns and its physiological relevance.

Authors:  Agnieszka Kaczmarek; Peter Vandenabeele; Dmitri V Krysko
Journal:  Immunity       Date:  2013-02-21       Impact factor: 31.745

3.  Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.

Authors:  N Holler; R Zaru; O Micheau; M Thome; A Attinger; S Valitutti; J L Bodmer; P Schneider; B Seed; J Tschopp
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

Review 4.  Molecular mechanisms of necroptosis: an ordered cellular explosion.

Authors:  Peter Vandenabeele; Lorenzo Galluzzi; Tom Vanden Berghe; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-08       Impact factor: 94.444

5.  Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells.

Authors:  D Vercammen; P Vandenabeele; R Beyaert; W Declercq; W Fiers
Journal:  Cytokine       Date:  1997-11       Impact factor: 3.861

6.  Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor.

Authors:  D Vercammen; R Beyaert; G Denecker; V Goossens; G Van Loo; W Declercq; J Grooten; W Fiers; P Vandenabeele
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

7.  Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways.

Authors:  D Vercammen; G Brouckaert; G Denecker; M Van de Craen; W Declercq; W Fiers; P Vandenabeele
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

Review 8.  Crashing the computer: apoptosis vs. necroptosis in neuroinflammation.

Authors:  Bradlee L Heckmann; Bart Tummers; Douglas R Green
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

Review 9.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  24 in total

Review 1.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

2.  Concise synthesis and biological activity evaluation of novel pyrazinyl-aryl urea derivatives against several cancer cell lines, which can especially induce T24 apoptotic and necroptotic cell death.

Authors:  Jia-Nian Chen; Chu-Ting Chen; Yue-Zhen He; Tai-Sheng Qin; Li Cheng; Ye-Xiang Sun; Kang-Jian Yang; Qi Chen; Chao Yang; Ying Wei
Journal:  RSC Med Chem       Date:  2021-11-11

Review 3.  Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases.

Authors:  A Justin Rucker; Francis Ka-Ming Chan
Journal:  Trends Biochem Sci       Date:  2022-01-05       Impact factor: 13.807

Review 4.  Disintegrin and Metalloproteinases (ADAMs [A Disintegrin and Metalloproteinase] and ADAMTSs [ADAMs With a Thrombospondin Motif]) in Aortic Aneurysm.

Authors:  Tolga Kilic; Keisuke Okuno; Satoru Eguchi; Zamaneh Kassiri
Journal:  Hypertension       Date:  2022-05-11       Impact factor: 9.897

Review 5.  The regulation of necroptosis by ubiquitylation.

Authors:  Yiliang Chen; Wenqing Ren; Qingsong Wang; Yuan He; Dan Ma; Zhenyu Cai
Journal:  Apoptosis       Date:  2022-08-08       Impact factor: 5.561

Review 6.  Understanding Necroptosis in Pancreatic Diseases.

Authors:  Ru He; Zhengfeng Wang; Shi Dong; Zhou Chen; Wence Zhou
Journal:  Biomolecules       Date:  2022-06-13

7.  Mosaic composition of RIP1-RIP3 signalling hub and its role in regulating cell death.

Authors:  Xin Chen; Rongfeng Zhu; Jinjin Zhong; Yongfa Ying; Wenxin Wang; Yating Cao; Hanyi Cai; Xiang Li; Jianwei Shuai; Jiahuai Han
Journal:  Nat Cell Biol       Date:  2022-03-07       Impact factor: 28.213

8.  Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL.

Authors:  Ashish Sethi; Christopher R Horne; Cheree Fitzgibbon; Karyn Wilde; Katherine A Davies; Sarah E Garnish; Annette V Jacobsen; André L Samson; Joanne M Hildebrand; Ahmad Wardak; Peter E Czabotar; Emma J Petrie; Paul R Gooley; James M Murphy
Journal:  Cell Death Differ       Date:  2022-03-09       Impact factor: 12.067

9.  Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis.

Authors:  Sarah E Garnish; Yanxiang Meng; Akiko Koide; Jarrod J Sandow; Eric Denbaum; Annette V Jacobsen; Wayland Yeung; Andre L Samson; Christopher R Horne; Cheree Fitzgibbon; Samuel N Young; Phoebe P C Smith; Andrew I Webb; Emma J Petrie; Joanne M Hildebrand; Natarajan Kannan; Peter E Czabotar; Shohei Koide; James M Murphy
Journal:  Nat Commun       Date:  2021-04-13       Impact factor: 14.919

10.  Genomic locus proteomic screening identifies the NF-κB signaling pathway components NFκB1 and IKBKG as transcriptional regulators of Ripk3 in endothelial cells.

Authors:  Siqi Gao; Matthew Menendez; Katarzyna Kurylowicz; Courtney T Griffin
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.